Integrum Partners with Implantcast Benelux to Further Drive Benelux Market for Bone-Anchored Prosthetics
Integrum and Implantcast Benelux have entered into a collaboration focused on the Benelux region. Integrum’s OPRA™ Implant System is an innovative technology aimed at helping improve the quality of life for amputees. Together Integrum and Implantcast Benelux aim to increase adoption for bone-anchored prosthetic technology in key surgical centers in Belgium and the Netherlands.
“We are pleased to partner with Implantcast on the Belgian and the Netherland markets, this will increase our presence, and by having a local partner we will strengthen our footprint in the Benelux region“, remarked Maria Lopez, Integrum’s CEO.
“The collaboration with Integrum is a fantastic opportunity and a logical step to be able to optimally serve our customers and end users” Nico Kampman, Managing Director Implantcast Benelux.
This information is such that Integrum AB (publ) is required to publish in accordance with the EU Market Abuse Regulation and the Swedish Security Markets Act. The information was submitted for publication, through the agency by the contact persons set out below on October 27, 2021, at 8:30 pm (CEST).
For further information contact:
María López, CEO Integrum AB. Cell: +46 (0)70 846 10 69, Email: maria.lopez@integrum.se
Dennis Baecklund, CFO Integrum AB. Cell: +46 (0)725 566 869, Email: dennis.baecklund@integrum.se
Nico Kampman, Managing Director Implantcast Benelux. Cell: +31 (0)646 766 063, Email: n.kampman@implantcast.nl
Certified Adviser
Erik Penser Bank AB is Certified Adviser and can be reached at +46 (0)8 463 8000, Email: certifiedadviser@penser.se
About Integrum
Integrum AB is a publicly-traded company (INTEG B: Nasdaq First North exchange) based outside of Gothenburg, Sweden, with a US subsidiary in San Francisco, CA. Since 1990, osseointegration, the science behind the OPRA™ Implant System, has been helping individuals with amputations enjoy a dramatically improved quality of life. Thorough surgical experience gained over more than three decades, from more than 500 surgeries, in 14 countries, has led to the development of Integrum’s system for bone-anchored prostheses – a vastly superior alternative to the traditionally used socket prosthesis.
In December 2020, Integrum successfully completed what may be considered the most stringent medical device regulatory procedure in the world, and based on the solid scientific data submitted, was granted a PMA by the FDA for the OPRA™ Implant System, which is the only technology approved for above-knee, bone-anchored prosthetics in the U.S. More information on the company and its innovative solutions for amputees can be found at www.integrum.se
About Implantcast Benelux
Implantcast Benelux is a subsidiary of Implantcast GmbH, founded in 2007. Implantcast offers an extensive portfolio for primary and revision arthroplasties and is known for the MUTARS (modular universal tumor and revision system) which is used in extensive revision procedures and oncological resections.
Implantcast GmbH is a highly specialized and innovative (privately owned) medical technology company. The HQ is based in Buxtehude near Hamburg, Germany. The company operates in the fields of product development, manufacturing, sterile packaging as well as sales and distribution of primary, revision and tumor endoprostheses. At Implantcast we provide high-quality, dynamic technologies to the orthopaedic surgeon and patients to offer an ideal solution for each individual patient worldwide. The recent establishment of a logistics center allows us to export our products to more than 65 countries worldwide.